Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthyWay's earnings before interest and taxes (EBIT) for the
six
months ended in Dec. 2025 was HK$55 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$68 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
HealthyWay's annualizedROC % for the quarter that ended in Dec. 2025 was 37.77%.
HealthyWay's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 821.67%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
HealthyWay's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 4.29%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthyWay EBIT Related Terms
HealthyWay EBIT Historical Data
* Premium members only.
The historical data trend for HealthyWay's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HealthyWay's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthyWay EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthyWay's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where HealthyWay's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthyWay (HKSE:02587) has a EBIT of HK$68 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthyWay.
Is HealthyWay's EBIT too high?
HealthyWay's current EBIT is HK$68 Mil. Overall, HealthyWay has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does HealthyWay's EBIT compare to VEEV and BTSG?
HealthyWay's EBIT of HK$68 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthyWay. HealthyWay's current EBIT is HK$68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthyWay stock overvalued right now?
HealthyWay (HKSE:02587) has a current EBIT of HK$68 Mil. The current EBIT is HK$68 Mil. HealthyWay's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For HealthyWay (HKSE:02587), the current EBIT is HK$68 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HealthyWay Inc operates a digital health and medical service platform in China. It has two main business segments: health and medical services; and corporate and digital marketing services. The health and medical services enable It to build an extensive connection between the supply and demand sides of the digital health and wellness market. The corporate services (especially content services) can benefit from its nationwide physician network, because it can develop corporate services that cover a wider range of medical specialties. The company generates the majority of its revenue from the corporate and digital marketing services.
13GF Score
Get the complete analysis for HKSE:02587
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02587 has been successfully added to your 
